IP Library › Granted Patent US 9,839,633
Granted Patent B2
US 9,839,633 · App. 13/444,381 · Granted Dec 12, 2017

Method and composition for treating rhinitis

Inventors: Lena Pereswetoff-Morath (Stockholm, SE); Anders Carlsson (Stockholm, SE)
Assignee: Biolipox AB
A61K31/495A61K9/0043A61K9/0048A61K9/127
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,839,633
App. No.
13/444,381
Granted
Dec 12, 2017
Kind
B2
Abstract

There is provided pharmaceutical compositions for the treatment of rhinitis by, for example, nasal or ocular administration comprising zwitterionic cetirizine, a polar lipid liposome and a pharmaceutical acceptable aqueous carrier. The compositions are preferably homogeneous in their nature.

Claims (3)

1. A method for the treatment of rhinitis comprising the administration of a pharmaceutical composition comprising zwitterionic cetirizine, a polar lipid liposome and a pharmaceutically-acceptable aqueous carrier, wherein the concentration of zwitterionic cetirizine is substantially similar in the aqueous carrier both within and surrounding the liposomes, and the diameter of the liposomes is less than about 200 nm to a person suffering from or susceptible to that disorder.

2. A method as claimed in claim 1 , wherein the administration is intranasal.

3. A method as claimed in claim 1 , wherein the administration is intraocular.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 30, 2012
From: PERESWETOFF-MORATH, LENA; CARLSSON, ANDERS
To: BIOLIPOX AB
Reel/Frame 029211/0894 →
Continuity (2)
Continuation 10571330
Related Publication 20130039969A1 · Feb 14, 2013